Abstract
Glycoprotein (GP)‐specific platelet‐associated IgG (PA‐IgG) may be demonstrable in autoimmune‐mediated thrombocytopenia. We studied 159 consecutive patients with histories of thrombocytopenia by a modified direct monoclonal antibody‐specific immobilization of platelet antigens (direct MAIPA) assay, which immobilizes GP IIb/IIIa, GP Ib/IX and GP Ia/IIa simultaneously. This modification requires smaller quantities of platelets than standard measurements performed separately. PA‐IgG was present in 84/159 (53%) patients, as shown by the direct platelet immunofluorescence test (PIFT) with flow cytometry as a reference. PA‐IgG against GP IIb/IIIa and/or GP Ib/IX and/or GP Ia/IIa was noted in 46 patients (29%), of whom 93% (43/46) were also PA‐IgG positive. The amount of PA‐IgG detected by PIFT correlated directly with that detected by direct MAIPA (r=0.71; PP<0.001). Direct PIFT and direct MAIPA divided the patients into asymmetric subgroups. However, the relative roles of these tests in the diagnosis of autoimmune‐mediated thrombocytopenia await further studies.